NYSE: ASPNAspen Aerogels Inc Stock
$11.33-0.32 (-2.75%)
Updated Jan 22, 2025
ASPN Price
$11.33
Fair Value Price
N/A
Market Cap
$929.60M
52 Week Low
$10.75
52 Week High
$33.15
P/E
566.5x
P/B
1.83x
P/S
5.1x
PEG
1.84x
Dividend Yield
N/A
Revenue
$413.83M
Earnings
$1.49M
Gross Margin
40%
Operating Margin
1.98%
Profit Margin
0.4%
Debt to Equity
0.54
Operating Cash Flow
$7M
Beta
1.63
Next Earnings
Feb 10, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ASPN Overview
Aspen Aerogels, Inc. manufactures aerogel insulation products used in the energy infrastructure and building materials markets in the U.S. and internationally. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries, and Pyrogel XTE which reduces the risk of corrosion under insulation in energy infrastructure operating systems. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market. Cryogel X201 is used in cold systems. Aspen was founded in 2001 and is headquartered in Northborough, MA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ASPN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
B
Growth
D
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Product & Equipment
Industry Rating
B
ASPN
Ranked#26 of 30
Ranked#26 of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $24.55 | A | |
| $187.57 | A | |
| $16.57 | B |
Be the first to know about important ASPN news, forecast changes, insider trades & much more!
ASPN News
Overview
Due Diligence Score
–
Industry Average (41)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ASPN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ASPN ($11.33) is trading above its intrinsic value of $2.18, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASPN is poor value based on its earnings relative to its share price (566.5x), compared to the US market average (30.67x)
P/E vs Market Valuation
ASPN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ASPN due diligence checks available for Premium users.
Valuation
ASPN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
566.5x
Industry
28.67x
Market
30.67x
ASPN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ASPN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ASPN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.83x
Industry
5.47x
ASPN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ASPN price to earnings growth (PEG)
For valuing profitable companies with growth potential
ASPN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ASPN's financial health
Profit margin
Revenue
$117.3M
Net Income
-$13.0M
Profit Margin
-11.1%
ASPN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ASPN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$782.6M
Liabilities
$274.9M
Debt to equity
0.54
ASPN's short-term assets ($305.86M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASPN's short-term assets ($305.86M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASPN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ASPN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$20.8M
Investing
-$20.8M
Financing
$22.2M
ASPN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ASPN vs Building Product & Equipment Stocks
Aspen Aerogels Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.